A suggested mechanism of generation and access of AA to brain targets is the following (Fig. 5): cell death (e.g. dopaminergic cell death in PD) and the related neuroinflammatory milieu, may generate soluble neuronal autoantigens (in this case modified AT1 receptors and ACE2) that reach the CSF. The gene discussed is AGTR1; the disease is Parkinson disease.